News

A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...
The scientist, Dr. Fiona Havers, told colleagues at the Centers for Disease Control and Prevention on Monday that she no ...
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
A CDC official who oversaw the agency’s Respiratory Virus Hospitalization Surveillance Network, known as RESP-NET, has resigned, citing concerns about how the data will be used to inform vaccine ...
The advisers to the Centers for Disease Control and Prevention will meet on June 25 and 26 to vote on who should receive shots for respiratory syncytial virus and influenza, according to a draft ...
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...